Trial intelligence / Profile preview

Dienogest vs GnRHa Pretreatment in Endometriosis IVF

NCT04500743Completed

Start
Aug 2018
Primary completion
Oct 2019
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial of dienogest in endometriosis (2 arms). Primary endpoint: Number of retrieved oocytes at 3 months. Started Aug 2018; status: completed.

02

Drugs

dienogest
03

Conditions

endometriosis

Beyond the preview

Go deeper on NCT04500743.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04500743.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call